Your browser doesn't support javascript.
loading
Clinical pharmacists in promoting the rational use of angiotensin-converting enzyme inhibitors in the CCU / 药学实践杂志
Journal of Pharmaceutical Practice ; (6): 472-474,478, 2017.
Artículo en Chino | WPRIM | ID: wpr-790798
ABSTRACT
Objective To improve the rational use of angiotensin-converting enzyme inhibitors (ACEI).Methods Clinical pharmacists reviewed ACEI use for the patients admitted into coronary heart disease care unit (CCU) during May 2012 to May 2013 to analyze the rational use of ACEI according to the expert consensus standards, guidelines and drug instructions of ACEI without any interventions.Clinical pharmacists intervened the irrational use of ACEI based on the same standard from June 2013 to May 2015.Results By comparing the data before and after intervention, it was found that the percentage of ACEI use increased from 80.1% to 98.9%.The percentage of initial ACEI overdose was dropped from 21.4% to 0.9%, and the percentage of under dose was decreased from 4.7% to 0.5%, which was statistically significant.Conclusion Clinical pharmacists can play a leading role in promoting the rational use of ACEI.

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Tipo de estudio: Guía de Práctica Clínica Idioma: Chino Revista: Journal of Pharmaceutical Practice Año: 2017 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Tipo de estudio: Guía de Práctica Clínica Idioma: Chino Revista: Journal of Pharmaceutical Practice Año: 2017 Tipo del documento: Artículo